In the influenza-positive elderly, oseltamivir significantly reduced the incidence of specified lower respiratory tract complications (mainly bronchitis) treated with antibiotics from 19% (52/ 268) in the placebo group to 12% (29/ 250) in the oseltamivir treated population (p = 0.0156).